Genome-Wide CRISPR-Cas9 Screens Expose Genetic Vulnerabilities and Mechanisms of Temozolomide Sensitivity in Glioblastoma Stem Cells
2019 · Cell Reports · 237 citations
https://doi.org/10.1016/j.celrep.2019.03.047
X
Xiaoguang Hao
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
41
Papers
974
Citations
12
h-index
14
i10-index
Xiaoguang Hao is an academic researcher from University of Calgary. The author has contributed to research in topics: Glioma Diagnosis and Treatment & Epigenetics and DNA Methylation & Cancer Cells and Metastasis. The author has an h-index of 12, co-authored 35 publications.
ORCID: 0000-0003-2695-0111Papers by this author
worksSingle-cell chromatin accessibility profiling of glioblastoma identifies an invasive cancer stem cell population associated with lower survival
2021 · eLife · 95 citations
https://doi.org/10.7554/elife.64090
Epigenetic and molecular coordination between HDAC2 and SMAD3-SKI regulates essential brain tumour stem cell characteristics
2023 · Nature Communications · 23 citations
https://doi.org/10.1038/s41467-023-40776-y
Temozolomide resistant human brain tumor stem cells are susceptible to recombinant vesicular stomatitis virus and double-deleted Vaccinia virus in vitro
2017 · Biomedicine & Pharmacotherapy · 12 citations
https://doi.org/10.1016/j.biopha.2017.09.030
Single-cell chromatin accessibility in glioblastoma delineates cancer stem cell heterogeneity predictive of survival
2018 · bioRxiv (Cold Spring Harbor Laboratory) · 8 citations
https://doi.org/10.1101/370726
A novel approach to target metastases of melanoma cells in an organ-selective manner
2014 · Journal of Translational Medicine · 4 citations
https://doi.org/10.1186/1479-5876-12-s1-p2
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat